Analysing breast cancer survivors' acceptance profiles for using an electronic pillbox connected to a smartphone application using Seintinelles, a French community-based research tool.
[en] Introduction: Up to 50% of breast cancer (BC) survivors discontinue their adjuvant endocrine therapy (AET) before the recommended 5 years, raising the issue of medication non-adherence. eHealth technologies have the potential to support patients to enhance their medication adherence and may offer an effective way to complement the healthcare. In order for eHealth technologies to be successfully implemented into the healthcare system, end-users need to be willing and accepting to use these eHealth technologies. Aim: This study aims to evaluate the current usability of eHealth technologiesin and to identify differences in BC SURVIVORS BC survivors accepting a medication adherence enhancing eHealth technology to support their AET to BC survivors that do not accept such a medication adherence enhancing eHealth technology. Methods: This study was conducted in 2020 including volunteering BC survivors belonging to the Seintinelles Association. Eligible participants were women, diagnosed with BC within the last 10 years, and been exposed to, an AET. Univariable and multivariable logistic regression analyses were performed to investigate medication adherence enhancing eHealth technology acceptance profiles among BC survivors. The dependent variable was defined as acceptance of an electronic pillbox connected to a smartphone application (hereafter: medication adherence enhancing eHealth technology). Results: Overall, 23% of the participants already use a connected device or health application on a regular basis. The mean age of the participants was 52.7 (SD 10.4) years. In total, 67% of 1268 BC survivors who participated in the survey declared that they would accept a medication adherence enhancing eHealth technology to improve their AET. BC survivors accepting a medication adherence enhancing eHealth technology for their AET, are younger (OR = 0.97, 95% CI [0.95; 0.98]), do take medication for other diseases (OR = 0.31, 95% CI [0.13; 0.68]), already use a medication adherence enhancing eHealth technology or technique (OR = 1.74, 95% CI [1.06; 2.94]) and are willing to possess or currently possess one or more connected devices or health applications (OR = 2.89, 95% CI [2.01; 4.19]). Conclusion: Understanding acceptance profiles of BC survivors is fundamental for conceiving an effective eHealth technology enhancing AET among BC survivors. Hence, such profiling will foster the development of personalized medication adherence enhancing eHealth technology.
Disciplines :
Public health, health care sciences & services
Author, co-author :
GOETZINGER, Catherine Joëlle ; University of Luxembourg ; Deep Digital Phenotyping Research Unit, Department of Precision Health, Luxembourg Institute of Health, Strassen, Luxembourg
Alleaume, Caroline; Santé Publique France, Paris, France
Schritz, Anna; Competence Center for Methodology and Statistics, Luxembourg Institute of Health, Strassen, Luxembourg
Vrijens, Bernard; AARDEX Group & Department of Public Health, Liège University, Liège, Belgium
Préau, Marie; Institut de Psychologie, Université Lumière Lyon 2, Lyon, France
FAGHERAZZI, Guy ; University of Luxembourg ; Deep Digital Phenotyping Research Unit, Department of Precision Health, Luxembourg Institute of Health, Strassen, Luxembourg
HUIART, Laetitia ; University of Luxembourg ; Santé Publique France, Paris, France
External co-authors :
yes
Language :
English
Title :
Analysing breast cancer survivors' acceptance profiles for using an electronic pillbox connected to a smartphone application using Seintinelles, a French community-based research tool.
Aguayo G. A. Goetzinger C. Scibilia R. Fischer A. Till S. Tran V.-T. et al. (2021). Methods to generate innovative research ideas and improve patient and public involvement in modern epidemiological research: Review, patient viewpoint, and guidelines for implementation of a digital cohort study. J. Med. Internet Res. 23 (12), e25743. 10.2196/25743
Ahmed I. Ahmad N. S. Ali S. George A. Danish H. S. Uppal E. et al. (2018). Medication adherence apps: Review and content analysis. JMIR Mhealth Uhealth 6 (3), e62. 10.2196/mhealth.6432
AshaRani P. V. Jue Hua L. Roystonn K. Siva Kumar F. D. Peizhi W. Ying Jie S. et al. (2021). Readiness and acceptance of eHealth services for diabetes care in the general population: Cross-sectional study. J. Med. Internet Res. 23 (9), e26881. 10.2196/26881
Bauquier C. Pannard M. Préau M. (2017). The seintinelles: An innovative approach to promoting community-based research and sustaining health democracy in oncology. Sante publique 29 (4), 547–550. 10.3917/spub.174.0547
Bouhnik A.-D. Bendiane M.-K. Cortaredona S. Sagaon Teyssier L. Rey D. Berenger C. et al.members of VICAN Group (2015). The labour market, psychosocial outcomes and health conditions in cancer survivors: Protocol for a nationwide longitudinal survey 2 and 5 Years after cancer diagnosis (the VICAN survey). BMJ Open 5 (3), e005971. 10.1136/bmjopen-2014-005971
Car J. Huckvale K. Hermens H. (2012). Telehealth for long term conditions. BMJ 344, e4201. 10.1136/bmj.e4201
Car J. Tan W. S. Huang Z. Sloot P. Franklin B. D. (2017). eHealth in the future of medications management: Personalisation, monitoring and adherence. BMC Med. 15 (1), 73. 10.1186/s12916-017-0838-0
Currie M. Philip L. J. Roberts A. (2015). Attitudes towards the use and acceptance of eHealth technologies: A case study of older adults living with chronic pain and implications for rural healthcare. BMC Health Serv. Res. 15, 162. 10.1186/s12913-015-0825-0
Davies C. Godwin J. Gray R. Clarke M. Cutter D. Darby S. et al.Early Breast Cancer Trialists’ Collaborative Group (EBCTCG) (2011). Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: Patient-level meta-analysis of randomised trials. Lancet 378 (9793), 771–784. 10.1016/s0140-6736(11)60993-8
De Geest S. Zúñiga F. Brunkert T. Deschodt M. Zullig L. L. Wyss K. et al. (2020). Powering Swiss health care for the future: Implementation science to bridge ‘the valley of death. Swiss Med. Wkly. 150, w20323. 10.4414/smw.2020.20323
Drewes C. Kirkovits T. Schiltz D. Schinkoethe T. Haidinger R. Goldmann-Posch U. et al. (2016). EHealth acceptance and new media preferences for therapy assistance among breast cancer patients. JMIR cancer 2 (2), e13. 10.2196/cancer.5711
Fagherazzi G. Zhang L. Aguayo G. Pastore J. Goetzinger C. Fischer A. et al. (2021). Towards precision cardiometabolic prevention: Results from a machine learning, semi-supervised clustering approach in the nationwide population-based ORISCAV-LUX 2 study. Sci. Rep. 11 (1), 16056. 10.1038/s41598-021-95487-5
Finitsis D. J. Vose B. A. Mahalak J. G. Salner A. L. (2019). Interventions to promote adherence to endocrine therapy among breast cancer survivors: A meta-analysis. Psychooncology. 28 (2), 255–263. 10.1002/pon.4959
Gire N. Caton N. McKeown M. Mohmed N. Duxbury J. Kelly J. et al. (2021). Care co-ordinator in my pocket': A feasibility study of mobile assessment and therapy for psychosis (TechCare). BMJ open 11 (11), e046755. 10.1136/bmjopen-2020-046755
Goetzinger C. B. Vrijens G. Fagherazzi M. Preau J. Mancini M. K. Ben-Dianeet al. (2021). “Beliefs and attitudes towards an ehealth tool to improve medication adherence in breast cancer survivors” in In Abstracts of the 24th Annual Meeting of ESPACOMP, the International Society for Medication Adherence, November 10–20, 2020. Int J Clin Pharm 43, 286–308. 10.1007/s11096-020-01213-Y
Hadji P. Blettner M. Harbeck N. Jackisch C. Lück H-J. Windemuth-Kieselbach C. et al. (2013). The patient’s Anastrozole compliance to therapy (pact) program: A randomized, in-practice study on the impact of a standardized information program on persistence and compliance to adjuvant endocrine therapy in postmenopausal women with early breast cancer. Ann. Oncol. 24, 1505–1512. 10.1093/annonc/mds653
Huiart L. Dell'Aniello S. Suissa S. (2011). Use of tamoxifen and aromatase inhibitors in a large population-based cohort of women with breast cancer. Br. J. Cancer 104 (10), 1558–1563. 10.1038/bjc.2011.140
Hurtado-de-Mendoza A. Jensen R. E. Jennings Y. Sheppard V. B. (2017). Understanding breast cancer survivors' beliefs and concerns about adjuvant hormonal therapy: Promoting adherence. J. Cancer Educ. 33, 436–439. 10.1007/s13187-017-1180-0
International Agency for Research on Cancer, European Network of Cancer Registries, Joint Reserach Center. 2020 Cancer incidence and mortality in EU-27 countries 2020. Available from: https://ec.europa.eu/jrc/en/news/2020-cancer-incidence-and-mortality-eu-27-countries. Accessed date 22/07/2020.
Kantsiper M. McDonald E. L. Geller G. Shockney L. Snyder C. Wolff A. C. (2009). Transitioning to breast cancer survivorship: Perspectives of patients, cancer specialists, and primary care providers. J. General Intern. Med. 24 (2), 459–466. 10.1007/s11606-009-1000-2
Kardas P. Pawel L. Matyjaszczyk M. (2013). Determinants of patient Adherence: A review of systematic reviews. Front. Pharmacol. 4, 91. 10.3389/fphar.2013.00091
Kini V. Michael Ho P. (2018). Interventions to improve medication adherence: A review. JAMA J. Am. Med. Assoc. 320, 2461–2473. 10.1001/jama.2018.19271
Konstantinou P. Kassianos A. P. Georgiou G. Panayides A. Papageorgiou A. Almas I. et al. (2020). Barriers, facilitators, and interventions for medication adherence across chronic conditions with the highest non-adherence rates: A scoping review with recommendations for intervention development. Transl. Behav. Med. 10 (6), 1390–1398. 10.1093/tbm/ibaa118
Lu C. Y. Zhang F. Wagner A. K. Nekhlyudov L. Earle C. C. Callahan M. et al. (2018). Impact of high-deductible insurance on adjuvant hormonal therapy use in breast cancer. Breast Cancer Res. Treat. 171 (1), 235–242. 10.1007/s10549-018-4821-z
Nieuwlaat R. Wilczynski N. Navarro T. Hobson N. Jeffery R. Keepanasseril A. et al. (2014). Interventions for enhancing medication adherence. Cochrane Database Syst. Rev. 2014 (11), Cd000011. 10.1002/14651858.CD000011.pub4
Pannard M. Bauquier C. Bassoleil L. Sablone L. Jacob G. Reyal F. et al. (2020). Citizens who volunteer as participants for cancer research-results of the Seintinelles Barometer 2018. Bull. Cancer 107 (3), 333–343. 10.1016/j.bulcan.2019.11.012
Partridge A. H. Wang P. S. Winer E. P. Avorn J. (2003). Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer. J. Clin. Oncol. 21 (4), 602–606. 10.1200/JCO.2003.07.071
Pistilli B. Paci A. Ferreira A. R. Di Meglio A. Poinsignon V. Bardet A. et al. (2020). Serum detection of nonadherence to adjuvant tamoxifen and breast cancer recurrence risk. J. Clin. Oncol. 38 (24), 2762–2772. 10.1200/JCO.19.01758
Pouls B. P. H. Vriezekolk J. E. Bekker C. L. Linn A. J. van Onzenoort H. A. W. Vervloet M. et al. (2021). Effect of interactive ehealth interventions on improving medication adherence in adults with long-term medication: Systematic review. J. Med. Internet Res. 23 (1), e18901. 10.2196/18901
Ringwald J. Marwedel L. Junne F. Ziser K. Schäffeler N. Gerstner L. et al. (2017). Demands and needs for psycho-oncological eHealth interventions in women with cancer: Cross-sectional study. JMIR cancer 3 (2), e19. 10.2196/cancer.7973
Rosenberg S. M. Petrie K. J. Stanton A. L. Ngo L. Finnerty E. Partridge A. H. (2020). Interventions to enhance adherence to oral antineoplastic agents: A scoping review. J. Natl. Cancer Inst. 112 (5), 443–465. 10.1093/jnci/djz244
Ross J. Stevenson F. Lau R. Murray E. (2016). Factors that influence the implementation of E-health: A systematic review of systematic reviews (an update). Implement. Sci. 11 (1), 146. 10.1186/s13012-016-0510-7
Sabaté E. World Health Organization (2003). Adherence to long-term therapies: Evidence for action. Geneva, Switzerland: World Health Organization.
Talal A. H. McLeod A. Andrews P. Nieves-McGrath H. Chen Y. Reynolds A. et al. (2019). Patient reaction to telemedicine for clinical management of hepatitis C virus integrated into an opioid treatment program. Telemed. J. E. Health. 25 (9), 791–801. 10.1089/tmj.2018.0161
Touillaud M. Fournier B. Pérol O. Delrieu L. Maire A. Belladame E. et al. (2021). Connected device and therapeutic patient education to promote physical activity among women with localised breast cancer (DISCO trial): Protocol for a multicentre 2×2 factorial randomised controlled trial. BMJ Open 11 (9), e045448. 10.1136/bmjopen-2020-045448
Vrijens B. De Geest S. Hughes D. A. Przemyslaw K. Demonceau J. Ruppar T. et al. (2012). A new taxonomy for describing and defining adherence to medications. Br. J. Clin. Pharmacol. 73 (5), 691–705. 10.1111/j.1365-2125.2012.04167.x
World Health Organization (2022) World health organization - regional office for the eastern mediterranean, Available at: http://www.emro.who.int/health-topics/ehealth/. Accessed July 25, 2022.
